Maladaptive 5-HT raphe-corticolimbic plasticity underlying the development of nonmotor symptoms in parkinson's disease
Active Project Grant Awarded Last action
- Award ID
- HT94252410624
- Recipient
-
Dignity Health UEI SKX6AXF9ZTM3 Part of Commonspirit Health
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $649,762
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 52% complete
- Place of performance
- Phoenix, AZ 85013, USA
Award details come from USAspending.gov.
About this award
This $649,762 federal Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research by Dignity Health's St. Joseph's Hospital and Medical Center (Barrow Neurological Institute) to investigate maladaptive 5-HT raphe-corticolimbic plasticity underlying the development of non-motor symptoms in Parkinson's disease. The award period runs from September 30, 2024 through September 29, 2028. As a prime recipient, Dignity Health will lead this innovative biomedical research to transform healthcare for military service members and the broader public, with a focus on understanding and potentially treating Parkinson's disease. The award leverages Dignity Health's expertise in neurodegenerative diseases and its established track record of conducting federally-funded research through both contract and grant mechanisms.
Quick answers
Who received award HT94252410624?
HT94252410624 was awarded to Dignity Health by Defense Health Agency (Department of Defense) on September 30, 2024.
How much is award HT94252410624 worth?
$649,762 has been obligated on HT94252410624.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award